Tuberculosis re-emerges as a major threat as new drug-resistant strains develop because of mismanagement of the disease. At the beginning of the year, doctors at Mumbai’s P.D. Hinduja National Hospital and Medical Research Centre reported that they had 12 patients infected with TDR-TB, or totally drug-resistant tuberculosis, a condition in which the TB bacilli is resistant to all first- and second-line drugs used in the conventional treatment of the disease. Panic...
More »SEARCH RESULT
Will the new type of oral polio vaccine be effective?-N Gopal Raj
An oral polio vaccine strain that cannot revert to virulence is needed Wouldn't it be nice to have a better sort of oral polio vaccine? Widespread use of the oral vaccine has brought the eradication of polio tantalisingly within reach. Since 1988 when the world embarked on an effort to wipe out the disease entirely, the number of cases has fallen by 99.8 per cent. Developed by an American scientist, Albert Sabin,...
More »MoEF panel favours bauxite mining in Vizag tribal area-M Suchitra
Yet-to-be-made public report dismisses environmental concerns The high-level committee set up by the Union Ministry of Environment and Forests (MoEF) to study the socio-economic and ecological impacts of the proposed bauxite mining in Andhra Pradesh’s Visakhapatnam district has submitted its final report favouring mining. The committee concludes mining will not have any significant negative impact on the ecology. At the same time it recommends settling all claims under the Forest Rights...
More »Cipla shocks rivals by slashing cancer drug prices up to 75%-Divya Rajagopal
Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...
More »Patent to plunder -Amit Sengupta
India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »